CORZBy Calypso Research6 min read

Core Scientific (CORZ) Q1 2025 Earnings Analysis

Core’s Earnings Take a Dive But Stock Surfs Up 6.2%

Key Takeaways

Core Scientific (CORZ) reported Q1 2025 earnings with revenue of $80M, representing a -55.6% year-over-year change. The stock moved +6.2% on earnings day.

The bull case: Core Scientific’s strategic pivot to high-density colocation is well-timed to capitalize on AI demand, with strong execution and potential for large enterprise growth.

The bear case: The high concentration with CoreWeave and elevated CapEx tied to tariffs pose financial and operational risks, limiting short-term diversification and profitability.

Financial Highlights

  • Revenue: $80M (-55.6% YoY)
  • Gross Profit: $8M (10.3% margin, -33.0% YoY)
  • Operating Income: $-43M (-53.6% margin, -84.4% YoY)
  • Net Income: $581M
  • TTM Revenue: $411M

Stock Performance

  • Earnings Day Move: +6.2%
  • Year-to-Date: +5.6%
  • 1-Year Return: +71.3%
  • vs. S&P 500 (since earnings): -21.5%
  • vs. Nasdaq (since earnings): -20.2%

View live CORZ data, AI chat, and interactive debates on Calypso →

What Management Said

Here are the key debates and direct quotes from Core Scientific's Q1 2025 earnings call:

CoreWeave Concentration and Its Impact on Customer Diversification

Sentiment: Positive

"We value [CoreWeave] highly as a commercial counterparty to Core Scientific," and "we believe our execution will only breed confidence with hyperscalers as this year goes on." — Adam Sullivan
"Interest in [Grand Forks] has ranged from enterprises to content providers and some of the hyperscalers... we've seen interest from pretty much all segments for that location." — Matt Brown

Large Enterprise Opportunities vs. Hyperscaler Dynamics

Sentiment: Positive

"Large enterprises are continuing to develop their AI use cases... we’re seeing demand ranging from 50 megawatts to 100 megawatts," and "large enterprise could represent anchor tenants at some of the new locations we’re evaluating today." — Adam Sullivan
"Large enterprises, the timeline to get into final contract details are definitely faster than on the hyperscale side... these could represent significant anchor tenants for new sites." — Adam Sullivan

Tariff Impacts on Colocation Development Costs and Lease Rates

Sentiment: Mixed

"We believe the tariff changes will drive up lease rates over the near term... thinking about 5% to 10% more expensive on the CapEx side," and "there will be a commiserate increase in lease rates across the industry." — Adam Sullivan
"With our strong relationships with suppliers, we have good insights into availability... we’re not too concerned about not being able to take receipt of equipment." — Matt Brown

CapEx Structure and Financial Risk Management Associated with CoreWeave

Sentiment: Mixed

"There’s no effective change in our CapEx arrangement as a result of the escrow mechanism change... we will not make those payments until we receive the funds from CoreWeave." — Jim Nygaard
"The CoreWeave contract is not going to be replicated in the market... the NRC and MRC give and take will vary by client, but we’re excited about return profiles for large enterprises." — Adam Sullivan

Expansion Plans and M&A Strategy for High-Density Data Centers

Sentiment: Positive

"We are evaluating opportunities in the new generation of data center capacity... but we will also look at assets that give us diversity in workload." — Adam Sullivan
"We’re looking at a healthy mix of both sites and companies that have contracts with leading companies in the industry." — Adam Sullivan

Bull Case

Core Scientific’s strategic pivot to high-density colocation is well-timed to capitalize on AI demand, with strong execution and potential for large enterprise growth.

Bear Case

The high concentration with CoreWeave and elevated CapEx tied to tariffs pose financial and operational risks, limiting short-term diversification and profitability.

Looking Ahead

With revenue declining -55.6% year-over-year, investors will be watching for signs of a turnaround at Core Scientific, particularly around coreWeave Concentration and Its Impact on Customer Diversification. With operating margins at -53.6%, margin trends will remain a focal point. The market's positive reaction on earnings day suggests confidence in management's direction, and the next earnings report will be a key catalyst for the stock.

Frequently Asked Questions

What was Core Scientific's revenue in Q1 2025?

Core Scientific reported Q1 2025 revenue of $80M, representing a -55.6% year-over-year change.

Did Core Scientific beat earnings expectations in Q1 2025?

The stock rose +6.2% on earnings day, suggesting the results met or exceeded market expectations. The current bull case centers on: Core Scientific’s strategic pivot to high-density colocation is well-timed to capitalize on AI demand, with strong execution and potential for large enterprise growth.

What is the bull case for CORZ stock?

The bull case for CORZ centers on: Core Scientific’s strategic pivot to high-density colocation is well-timed to capitalize on AI demand, with strong execution and potential for large enterprise growth.

What is the bear case for CORZ stock?

The bear case for CORZ centers on: The high concentration with CoreWeave and elevated CapEx tied to tariffs pose financial and operational risks, limiting short-term diversification and profitability.

How has CORZ stock performed since its Q1 2025 earnings?

CORZ moved +6.2% on the day of its Q1 2025 earnings report, underperforming the S&P 500 by +21.5% since earnings. Year-to-date, the stock has returned +5.6%.

Browse all 400+ earnings reports →

Learn More

Analyze CORZ in Real Time

This is a static snapshot. For live financial data, AI-powered chat, and interactive earnings debates for Core Scientific and 400+ other stocks, explore the full platform.

Open CORZ on Calypso →

Calypso is an AI-powered equity research platform used by investment teams to cut earnings research time by over 80%.